This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.
You can find the current article at its original source at https://www.rt.com/news/517488-new-zealand-pfizer-vaccine-astrazeneca-concerns/
The article has changed 3 times. There is an RSS feed of changes available.
| Version 0 | Version 1 |
|---|---|
| New Zealand makes Pfizer its primary vaccine supplier after AstraZeneca jab concerns | New Zealand makes Pfizer its primary vaccine supplier after AstraZeneca jab concerns |
| (6 months later) | |
| New Zealand’s government has announced it has bought enough Covid-19 vaccines from Pfizer to inoculate its entire population following concerns about the effectiveness of the AstraZeneca jab, which the country initially ordered. | New Zealand’s government has announced it has bought enough Covid-19 vaccines from Pfizer to inoculate its entire population following concerns about the effectiveness of the AstraZeneca jab, which the country initially ordered. |
| New Zealand Prime Minister Jacinda Ardern announced the order from Pfizer and BioNTech on Monday, after increasing the country’s original request from 1.5 million doses to 10 million doses, enough to vaccinate the entire nation against Covid-19. | New Zealand Prime Minister Jacinda Ardern announced the order from Pfizer and BioNTech on Monday, after increasing the country’s original request from 1.5 million doses to 10 million doses, enough to vaccinate the entire nation against Covid-19. |
| “This brings our total Pfizer order to 10 million doses or enough for 5 million people to get the two shots needed to be fully vaccinated against COVID-19,” Ardern said. | “This brings our total Pfizer order to 10 million doses or enough for 5 million people to get the two shots needed to be fully vaccinated against COVID-19,” Ardern said. |
| The new batch of vaccines from Pfizer is expected to be delivered to New Zealand in the second half of 2021. | The new batch of vaccines from Pfizer is expected to be delivered to New Zealand in the second half of 2021. |
| The New Zealand prime minister explained that the government had decided to shift to Pfizer as its main vaccine provider after trial data showed the jab was 95 percent effective at preventing symptomatic infection. | The New Zealand prime minister explained that the government had decided to shift to Pfizer as its main vaccine provider after trial data showed the jab was 95 percent effective at preventing symptomatic infection. |
| Previously, the New Zealand government had picked AstraZeneca to supply the majority of its vaccines, ordering 7.6 million doses from the company, but has since changed its approach after trial results found it only provides minimal protection against new strains of the virus. | Previously, the New Zealand government had picked AstraZeneca to supply the majority of its vaccines, ordering 7.6 million doses from the company, but has since changed its approach after trial results found it only provides minimal protection against new strains of the virus. |
| University of Auckland associate professor Helen Petousis-Harris explained that the decision was taken because the data was “not the news we were looking for,” and warned the government “to be prepared to adapt to whatever the virus throws at us.” | University of Auckland associate professor Helen Petousis-Harris explained that the decision was taken because the data was “not the news we were looking for,” and warned the government “to be prepared to adapt to whatever the virus throws at us.” |
| New Zealand isn’t the only country to halt its use of the AstraZeneca vaccine after “disappointing” trial results. Despite buying 10 million Covid-19 vaccines from AstraZeneca, South Africa has stopped using it in its vaccine rollout because data showed it did “not work against mild and moderate illness” from Covid-19, choosing to give away their leftover, unused supply. | New Zealand isn’t the only country to halt its use of the AstraZeneca vaccine after “disappointing” trial results. Despite buying 10 million Covid-19 vaccines from AstraZeneca, South Africa has stopped using it in its vaccine rollout because data showed it did “not work against mild and moderate illness” from Covid-19, choosing to give away their leftover, unused supply. |
| Think your friends would be interested? Share this story! | Think your friends would be interested? Share this story! |
| Dear readers and commenters, | |
| We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system. | |
| Sorry for the inconvenience, and looking forward to your future comments, | |
| RT Team. |